Clinical Trial Update: Indo-cyanine Green (ICG) in Paediatric Oncology MIS [Phase 4]

View source ↗

Summary

Phase 4 trial update on using Indo-cyanine Green (ICG) in pediatric oncology, with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma
• Non-rhabdomyosarcoma Soft Tissue Sarcoma
• Osteosarcoma
• Pulmonary Metastasis
• Renal Tumor
• Rhabdomyosarcoma

Drugs mentioned

• Indo-cyanine Green (ICG) (Indocyanine green)

Snippet

Sponsor: Birmingham Women's and Children's NHS Foundation Trust | Conditions: Pediatric Renal Tumor, Metastatic Osteosarcoma | Phase 4 | Status: COMPLETED